Description
Products
4 productsBrand: Bambevi. Biosimilar to Avastin. Metastatic colorectal cancer, non-squamous NSCLC, ovarian/fallopian tube/peritoneal cancer, glioblastoma. 100 mg and 400 mg vials. Canada.
Filing submitted
Finished product (FDF)
Verified on 2026-10-21
Brand: Grastofil. Biosimilar to Neupogen. Chemotherapy-associated neutropenia, AML, bone marrow transplantation, progenitor cell mobilization, severe chronic neutropenia, neutropenia in HIV. Pre-filled syringe. Canada.
Filing submitted
Finished product (FDF)
Verified on 2026-10-21
Brand: Lapelga. Biosimilar to Neulasta. Decreases incidence of infection (febrile neutropenia) in non-myeloid malignancies on myelosuppressive chemotherapy. 6 mg/0.6 mL pre-filled syringe or autoinjector. Canada.
Filing submitted
Finished product (FDF)
Verified on 2026-10-21
Brand: Loqtorzi. Anti-PD-1 antibody (not a biosimilar). Metastatic or recurrent nasopharyngeal carcinoma. Concentrate for IV infusion 40 mg/mL. Canada.
Filing submitted
Finished product (FDF)
Verified on 2026-10-21